USH266H - Method of cerebrospinal fluid transfusion - Google Patents
Method of cerebrospinal fluid transfusion Download PDFInfo
- Publication number
- USH266H USH266H US06/912,099 US91209986A USH266H US H266 H USH266 H US H266H US 91209986 A US91209986 A US 91209986A US H266 H USH266 H US H266H
- Authority
- US
- United States
- Prior art keywords
- cerebrospinal fluid
- transfusion
- fluid transfusion
- blood
- donee
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000001175 cerebrospinal fluid Anatomy 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title claims abstract description 4
- 210000004369 blood Anatomy 0.000 claims abstract description 6
- 239000008280 blood Substances 0.000 claims abstract description 6
- 210000003462 vein Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000009593 lumbar puncture Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0464—Cerebrospinal fluid
Definitions
- the principal discovery is that human brain fluid and blood groups fully coincide, providing a method for the transfusion of cerebrospinal fluid.
- cerebrospinal fluid contains no specific anti-genes and anti-bodies and cannot therefore be grouped. In early experiments with transfusion of cerebrospinal fluid it was administered into the skin or into a vein.
- An important feature of this invention is that drops of cerebrospinal fluid mixed with reference erythrocytes representing different blood groups agglutinate, demonstrating that it divides into groups the same as blood.
- the transfusion of cerebrospinal fluid can help treat people with diseases that are otherwise difficult to treat; can influence their emotional state, memory and metabolism; and strengthen the body's immune systems.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A method of transfusing human cerebrospinal fluid, wherein the blood types of the donor and donee may be used to match compatible cerebrospinal fluid.
Description
The principal discovery is that human brain fluid and blood groups fully coincide, providing a method for the transfusion of cerebrospinal fluid.
Classical literature contends that cerebrospinal fluid contains no specific anti-genes and anti-bodies and cannot therefore be grouped. In early experiments with transfusion of cerebrospinal fluid it was administered into the skin or into a vein.
An important feature of this invention is that drops of cerebrospinal fluid mixed with reference erythrocytes representing different blood groups agglutinate, demonstrating that it divides into groups the same as blood.
There is therefore no need to make a lumbar puncture to establish the cerebrospinal group because the test of blood from a finger will do.
The discovery of groups for cerebrospinal fluid determines that transfusions are to be administered neither into the vein nor under the skin, as was done previously, but directly into those cavities where it is found. Approximately 20 grams are needed.
The transfusion of cerebrospinal fluid can help treat people with diseases that are otherwise difficult to treat; can influence their emotional state, memory and metabolism; and strengthen the body's immune systems.
Claims (1)
1. A method of transfusing cerebrospinal fluid comprising the steps of: Matching the blood types of a donor and donee and transfusing cerebrospinal fluid from the donor to the donee.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/912,099 USH266H (en) | 1986-09-29 | 1986-09-29 | Method of cerebrospinal fluid transfusion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/912,099 USH266H (en) | 1986-09-29 | 1986-09-29 | Method of cerebrospinal fluid transfusion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| USH266H true USH266H (en) | 1987-05-05 |
Family
ID=25431383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US06/912,099 Abandoned USH266H (en) | 1986-09-29 | 1986-09-29 | Method of cerebrospinal fluid transfusion |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | USH266H (en) |
-
1986
- 1986-09-29 US US06/912,099 patent/USH266H/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Herth | The relationship between level of hope and level of coping response and other variables in patients with cancer | |
| CH626256A5 (en) | Device for the continuous, extracorporal separation of specific substances from blood | |
| USH266H (en) | Method of cerebrospinal fluid transfusion | |
| US20040120937A1 (en) | Blood therapy process | |
| Kroll et al. | Hemodialysis and schizophrenia: A negative report | |
| Kliman et al. | Plasmapheresis as a form of blood donation | |
| Davis | Method in Jewish bioethics: An overview | |
| US4673385A (en) | Peritoneal membrane plasmapheresis | |
| Vercillo et al. | Jehovah's Witnesses and the transfusion of blood products. | |
| Persellin et al. | Serum antibody response in sarcoidosis. | |
| Maeshima et al. | Effects on cognitive function and activities of daily living after stereotactic thalamotomy for Parkinson's disease | |
| Bowman | IV. The Treatment of Alcoholism | |
| Zeller et al. | The passage of thiocyanate and glucose from the blood stream into the joint spaces | |
| Ryhänen et al. | Are changes in serum immunoglobulin and complement levels following open heart surgery influenced by oxygenator type or postoperative parenteral nutrition? | |
| Potgieter, GM, Smythe, PM & Kench | Serum proteins in kwashiorkor | |
| Saito | Band patterns of human sweat proteins carrying ABO-blood-group antigens tested by SDS-polyacrylamide gel electrophoresis | |
| Kinnear, AA & Pretorius | Liver function in fatal kwashiorkor | |
| Hanna | Epoietin alfa (EPO) for anemia | |
| Tunis et al. | Urinary Glycoproteins in Human Leukemia | |
| Liusov et al. | The effect of bee honey and flower pollen on the tolerance for physical loads, on lipid metabolism and on the rheological properties of the blood in patients with ischemic heart disease | |
| Roubinstein | Specificity of experimentation in pathopsychology. | |
| Neame | Erythroid hypoplasia in kwashiorkor | |
| Brennan | BRIEF SKILLS ENHANCEMENT COUNSELING WITH RENAL DIALYSIS PATIENTS. | |
| Tanimura et al. | Clinical application of a new intravenous fat emulsion," venolipid"(author's transl) | |
| Platt | Experimental Nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |